|
CHILLAS
China Intensive Lipid Lowering with statins in Acute coronary Syndrome
Ongoing trial
 |
Author(s) |
Zhao S-P, Peng D-Q, Yu B-L, Huo Y, CHILLAS investigators |
 |
Title(s) |
Rationale and design of China intensive lipid lowering with statins in acute coronary syndrome: The CHILLAS study |
|
Reference(s) |
Am Heart J 2009;158:509–12.e1 |
|
Disease |
Acute coronary syndromes |
|
Purpose |
To assess the effect of intensive lipid-lowering therapy with statins in patients with acute coronary syndromes |
|
Study design |
Randomised, open |
|
Follow-up |
Aim 2–5 years |
|
Patients |
Aim 1600 patients, aged 18–80 years, hospitalised for AMI or unstable angina pectoris, clinically stable for 24 h, with LDL cholesterol < 140 mg/dl and not taking atorvastatin > 10 mg/day (or equivalent dose of other statins) |
|
Treatment regimen |
Atorvastatin, 20–40 mg/day, or equivalent dose of other statins (intensive therapy), or atorvastatin, 10 mg/day, or equivalent dose of other statins (standard therapy) |
|
Concomitant therapy |
Dietary counselling |
|
Results |
Not yet available |
|
|
|
